Racial disparities found in facial paralysis diagnosis and treatment

A study using the TriNetX database analyzed 370,574 patients with facial paralysis diagnoses, comparing age- and sex-matched Caucasian and non-Caucasian (Black, Hispanic, Asian) cohorts. The study reported that non-Caucasian patients were diagnosed with facial paralysis at higher rates and at younger ages, had higher rates of type 2 diabetes and hypertension but lower rates of thyroid disease, and experienced more socioeconomic/psychosocial health hazards, yet received chemodenervation treatment less often than Caucasian patients. The authors state that future studies should investigate underlying differences in diagnosis and the true incidence of facial synkinesis across racial and ethnic groups.

Most relevant for: Patients diagnosed with facial paralysis, particularly regarding racial and ethnic differences in comorbidities and access to chemodenervation treatment.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.